In SURMOUNT-1, adults with obesity (without diabetes) lost an average of 15.0%, 19.5%, and 20.9% of body weight with tirzepatide 5 mg, 10 mg, and 15 mg respectively over 72 weeks, compared to 3.1% with placebo
The synthetic antimicrobial peptide pexiganan and its nanoparticles (PNPs) exhibit the anti-helicobacter pylori activity in vitro and in vivo
GHKs ability to improve tissue repair has been demonstrated for skin, lung connective tissue, bone tissue, liver, and stomach lining
Medical history, current medications, BMI criteria, insurance coverage, cost, and side effects all factor into the decision about whether Zepbound is a suitable weight loss treatment
Hypoglycemia risk is low in individuals without diabetes not taking other glucose-lowering medications
L-Carnitine helps shift the focus from using carbohydrates for energy to using stored fat